RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
8.43
-1.30 (-13.36%)
At close: Jun 27, 2025, 4:00 PM
8.42
-0.01 (-0.12%)
After-hours: Jun 27, 2025, 6:58 PM EDT
RAPT Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
68
Market Cap
139.40M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
RAPT News
- 5 days ago - RAPT Therapeutics Names Two Industry Veterans to its Board of Directors - GlobeNewsWire
- 14 days ago - RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split - GlobeNewsWire
- 23 days ago - RAPT Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - RAPT Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development - GlobeNewsWire
- 4 months ago - RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 months ago - RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors - GlobeNewsWire